A detailed history of Verition Fund Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Verition Fund Management LLC holds 47,300 shares of JNJ stock, worth $7.24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
47,300
Previous 85,900 44.94%
Holding current value
$7.24 Million
Previous $12.6 Million 38.95%
% of portfolio
0.04%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $5.64 Million - $6.49 Million
-38,772 Reduced 53.49%
33,716 $5.46 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $2.53 Million - $2.76 Million
-17,502 Reduced 19.45%
72,488 $10.6 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $69.8 Million - $73.2 Million
-449,651 Reduced 83.32%
89,990 $14.2 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $71.2 Million - $77.6 Million
488,699 Added 959.32%
539,641 $84.6 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $1.78 Million - $1.99 Million
-11,405 Reduced 18.29%
50,942 $7.93 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $5.12 Million - $5.51 Million
33,189 Added 113.82%
62,347 $10.3 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $4.69 Million - $5.6 Million
-31,063 Reduced 51.58%
29,158 $4.52 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $3.6 Million - $4.04 Million
-22,486 Reduced 27.19%
60,221 $10.6 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $10.6 Million - $11.8 Million
65,937 Added 393.18%
82,707 $13.5 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $263,217 - $291,105
-1,565 Reduced 8.54%
16,770 $2.98 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $1.56 Million - $1.78 Million
9,884 Added 116.96%
18,335 $3.25 Million
Q4 2021

May 03, 2022

SELL
$155.93 - $173.01 $3.41 Million - $3.79 Million
-21,900 Reduced 72.16%
8,451 $1.45 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $2.09 Million - $2.32 Million
13,411 Added 79.17%
30,351 $5.19 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $1.48 Million - $1.65 Million
-9,190 Reduced 35.17%
16,940 $2.74 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $3.7 Million - $3.97 Million
23,216 Added 796.71%
26,130 $4.31 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $399,538 - $458,605
2,914 New
2,914 $459,000
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $1.85 Million - $2.03 Million
-13,167 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $24.2 Million - $29.2 Million
-187,663 Reduced 93.44%
13,167 $1.85 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $19.7 Million - $27.4 Million
177,613 Added 765.01%
200,830 $26.3 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $2.12 Million - $2.43 Million
16,595 Added 250.6%
23,217 $3.39 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $2.15 Million - $2.41 Million
-16,965 Reduced 71.93%
6,622 $857,000
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $1.48 Million - $1.63 Million
-11,302 Reduced 32.39%
23,587 $3.29 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $76,437 - $84,992
-608 Reduced 1.71%
34,889 $4.88 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $93,726 - $112,801
763 Added 2.2%
35,497 $4.58 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $1.06 Million - $1.25 Million
8,739 Added 33.62%
34,734 $4.8 Million
Q2 2018

Aug 15, 2018

BUY
$119.4 - $131.76 $2.31 Million - $2.55 Million
19,365 Added 292.08%
25,995 $3.15 Million
Q1 2018

May 16, 2018

SELL
$125.1 - $148.14 $1.08 Million - $1.28 Million
-8,650 Reduced 56.61%
6,630 $850,000
Q4 2017

Feb 15, 2018

SELL
$131.22 - $143.62 $1.59 Million - $1.74 Million
-12,108 Reduced 44.21%
15,280 $2.14 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $3.55 Million - $3.71 Million
27,388
27,388 $3.56 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.